FI930577A0 - Vaccin och behandlingsmetod foer hiv-infektion - Google Patents

Vaccin och behandlingsmetod foer hiv-infektion

Info

Publication number: FI930577A0
Authority: FI; Finland
Prior art keywords: behandlingsmetod; infektion; vaccin; foer; hiv
Prior art date: 1991-06-11

Application number

FI930577A

Other languages

English (en)

Other versions

FI930577L (fi

Inventor

Gale E Smith

Franklin Volvovitz

Original Assignee

Microgenesys Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-11

Filing date

1993-02-10

Publication date

1993-02-10

1993-02-10 Application filed by Microgenesys Inc filed Critical Microgenesys Inc

1993-02-10 Publication of FI930577A0 publication Critical patent/FI930577A0/fi

1993-03-24 Publication of FI930577L publication Critical patent/FI930577L/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14041—Use of virus, viral particle or viral elements as a vector
- C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Immunology (AREA)
Hematology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

FI930577A 1991-06-11 1993-02-10 Vaccin och behandlingsmetod foer hiv-infektion FI930577L (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US71415291A	1991-06-11	1991-06-11
PCT/US1992/004980 WO1992022654A1 (en)	1991-06-11	1992-06-10	Vaccine and treatment method of human immunodeficiency virus infection

Publications (2)

Publication Number	Publication Date
FI930577A0 true FI930577A0 (fi)	1993-02-10
FI930577L FI930577L (fi)	1993-03-24

Family

ID=24868938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI930577A FI930577L (fi)	1991-06-11	1993-02-10	Vaccin och behandlingsmetod foer hiv-infektion

Country Status (18)

Country	Link
EP (1)	EP0542998A1 (fi)
JP (1)	JPH06501851A (fi)
CN (1)	CN1068266A (fi)
AU (2)	AU2193192A (fi)
BG (1)	BG97519A (fi)
CA (1)	CA2087732A1 (fi)
EE (1)	EE9400183A (fi)
FI (1)	FI930577L (fi)
HU (1)	HUT68355A (fi)
IE (1)	IE921875A1 (fi)
IL (1)	IL102092A (fi)
LT (1)	LT3365B (fi)
MX (1)	MX9202781A (fi)
PL (1)	PL297849A1 (fi)
PT (1)	PT100584A (fi)
SK (1)	SK18993A3 (fi)
WO (1)	WO1992022654A1 (fi)
ZA (1)	ZA924150B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE40786E1 (en) *	1984-03-16	2009-06-23	The United States Of America As Represented By The Secretary Of The Army	Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
US6479055B1 (en)	1993-06-07	2002-11-12	Trimeris, Inc.	Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) *	1993-06-07	1995-11-07	Duke University	Synthetic peptide inhibitors of HIV transmission
US6017536A (en) *	1993-06-07	2000-01-25	Trimeris, Inc.	Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
AU1377395A (en)	1993-12-23	1995-07-10	University Technologies International Inc.	Methods of expressing proteins in insect cells and methods of killing insects
JPH11507632A (ja)	1995-06-07	1999-07-06	トリメリス，インコーポレーテッド	併用療法を用いたｈｉｖおよび他のウイルス感染の治療
US6395541B1 (en)	1996-05-23	2002-05-28	The Rockefeller University	Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I
US6319504B1 (en)	1996-06-24	2001-11-20	University Of Maryland Biotechnology Institute	Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6077662A (en) *	1996-11-27	2000-06-20	Emory University	Virus-like particles, methods and immunogenic compositions
US6214540B1 (en)	1997-03-26	2001-04-10	University Of Maryland Biotechnology Institute	Chemokines that inhibit immunodeficiency virus infection and methods based thereon
US6583109B1 (en)	1997-06-24	2003-06-24	Robert C. Gallo	Therapeutic polypeptides from β-hCG and derivatives
US6548631B1 (en)	1997-09-16	2003-04-15	BIOMéRIEUX, INC.	Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection
US6750008B1 (en)	1999-07-09	2004-06-15	Trimeris, Inc.	Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
US7994278B1 (en)	1999-08-06	2011-08-09	Nobel Biosciences Llc	Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6623741B1 (en)	2000-02-29	2003-09-23	Trimeris, Inc.	Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission
AUPS065002A0 (en)	2002-02-20	2002-03-14	Immunaid Pty Ltd	Strategy for retroviral immunotherapy
US7901690B2 (en)	2002-12-03	2011-03-08	University Of Massachusetts	Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods
DE602004030369D1 (de)	2003-10-24	2011-01-13	Immunaid Pty Ltd	Therapieverfahren
GT200800303A (es)	2007-12-24	2009-09-18		Combinacion anti-retroviral
CA2763373C (en)	2009-05-27	2018-01-09	Immunaid Pty Ltd	Methods and systems for determining preferred times for administering therapy to treat diseases
CN103890173B (zh)	2011-08-19	2016-02-03	鸵鸟制药株式会社	抗体和含有抗体的组合物
CN102961760B (zh) *	2011-09-01	2017-07-18	常州文松生物技术有限公司	重叠肽作为制备皮肤试验和检测特异性细胞免疫的试剂及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL89118A0 (en) *	1988-02-03	1989-08-15	Microgenesys Inc	Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1

1992
- 1992-06-03 IL IL10209292A patent/IL102092A/en not_active IP Right Cessation
- 1992-06-08 ZA ZA924150A patent/ZA924150B/xx unknown
- 1992-06-10 HU HU9300686A patent/HUT68355A/hu unknown
- 1992-06-10 AU AU21931/92A patent/AU2193192A/en not_active Abandoned
- 1992-06-10 JP JP5501040A patent/JPH06501851A/ja active Pending
- 1992-06-10 PL PL29784992A patent/PL297849A1/xx unknown
- 1992-06-10 MX MX9202781A patent/MX9202781A/es unknown
- 1992-06-10 WO PCT/US1992/004980 patent/WO1992022654A1/en not_active Application Discontinuation
- 1992-06-10 SK SK18993A patent/SK18993A3/sk unknown
- 1992-06-10 CA CA002087732A patent/CA2087732A1/en not_active Abandoned
- 1992-06-10 EP EP92913889A patent/EP0542998A1/en not_active Withdrawn
- 1992-06-11 PT PT100584A patent/PT100584A/pt not_active Application Discontinuation
- 1992-06-11 CN CN92104517A patent/CN1068266A/zh active Pending
- 1992-07-01 IE IE187592A patent/IE921875A1/en not_active Application Discontinuation
1993
- 1993-02-10 FI FI930577A patent/FI930577L/fi not_active Application Discontinuation
- 1993-02-11 LT LTIP335A patent/LT3365B/lt not_active IP Right Cessation
- 1993-03-10 BG BG97519A patent/BG97519A/bg unknown
1994
- 1994-09-21 EE EE9400183A patent/EE9400183A/xx unknown
1995
- 1995-12-07 AU AU40288/95A patent/AU4028895A/en not_active Abandoned

Also Published As

Publication number	Publication date
IE921875A1 (en)	1992-12-16
PL297849A1 (en)	1994-01-24
LT3365B (en)	1995-07-25
IL102092A (en)	1996-11-14
IL102092A0 (en)	1993-01-14
BG97519A (bg)	1994-03-24
PT100584A (pt)	1993-07-30
JPH06501851A (ja)	1994-03-03
SK18993A3 (en)	1993-10-06
FI930577L (fi)	1993-03-24
AU2193192A (en)	1993-01-12
CN1068266A (zh)	1993-01-27
AU4028895A (en)	1996-02-22
HU9300686D0 (en)	1993-06-28
WO1992022654A1 (en)	1992-12-23
ZA924150B (en)	1993-02-24
LTIP335A (en)	1995-01-31
CA2087732A1 (en)	1992-12-12
MX9202781A (es)	1993-04-01
EP0542998A1 (en)	1993-05-26
EE9400183A (et)	1995-12-15
HUT68355A (en)	1995-06-28

Publication	Publication Date	Title
FI933224L (fi)	1993-07-15	Detergentkompositioner innehaollande lipas och vattenloesliga kvaternariska ammoniumfoereningar
FI921968L (fi)	1992-11-03	Flerlagrade monolitiska magnetiska komponenter och deras framstaellning
FI921105L (fi)	1992-09-16	Segmentpolyteramider och deras syntesprocess
FI933178L (fi)	1993-09-06	Antimikrobiellt smoerjmedel innehaollande fettsyra och kvartaera ammoniumfoereningar
FI925427L (fi)	1993-05-30	Styrkrets och foerfarande foer transmissionsutgaong
FI933937L (fi)	1993-09-08	Svavelbelagd konstgoedning och foerfarande foer framstaellning daerav
FI925533L (fi)	1993-06-07	Tantal- eller niobbaserad perovskit och foerfarande foer framstaellning daerav
FI924747L (fi)	1993-04-22	Peg-imidat och proteinderivat daerav
FI933379L (fi)	1993-07-28	Reglerenhet foer blandarventilao och kolvslid foer reglerenheten
FI923971L (fi)	1993-03-06	Bundna fiberbelaeggningssubstrater och foerfarande foer framstaellning daerav
FI930577A0 (fi)	1993-02-10	Vaccin och behandlingsmetod foer hiv-infektion
FI921940L (fi)	1992-11-04	Stabila pura-vektorer och deras anvaendning
FI912760A (fi)	1992-12-08	Skivfilter och filterelement foer skivfilter
FI921818L (fi)	1992-10-25	Hopknippningsanordning och foerfarande
FI925976L (fi)	1992-12-31	Termiskt stabila kompositioner och dessa innehaollande smoerjmedel och funktionella vaetskor
FI925234L (fi)	1992-11-18	Stabila polyamidhartsmikrodispersioner och foerfaranden foer deras framstaellning
FI922920A (fi)	1992-12-27	Separationsfoerfarande och anordning haerfoer
FI933452L (fi)	1993-09-16	Pmn-haerstammande cr3-modulator och anvaendning daerav
FI921741L (fi)	1992-10-21	En katalyt och belaeggningskomposition innehaollande densamma
FI925776L (fi)	1992-12-18	Oeverbasiska alkalmetallsalter och foerfaranden foer deras framstaellning
FI924083A (fi)	1993-03-18	Spaenningsdeviationkompensator foer slaecktid foer vaexelriktare och omformare
FI933841L (fi)	1993-09-02	Kodningsfoerfarande och kodningsanordning
FI933359L (fi)	1993-07-27	Fodertillsatsaemne och foerfarande
FI925252L (fi)	1993-05-22	Friktionstaoliga kompositmaterial och foerfarande foer deras framstaellning
FI923562L (fi)	1993-02-10	Vattenloesliga hartsbaserade belaeggningar och blaeck

Legal Events

Date	Code	Title	Description
1997-01-14	FD	Application lapsed